Právní předpis byl sestaven k datu 01.10.2015.
Zobrazené znění právního předpisu je účinné od 01.10.2015 do 28.02.2017.
Příloha č. 1 - Seznam č. 1 omamných látek
Příloha č. 2 - Seznam č. 2 omamných látek
Příloha č. 3 - Seznam č. 3 omamných látek
Příloha č. 4 - Seznam č. 4 psychotropních látek
Příloha č. 5 - Seznam č. 5 psychotropních látek
Příloha č. 6 - Seznam č. 6 psychotropních látek
Příloha č. 7 - Seznam č. 7 psychotropních látek
Příloha č. 8 - Seznam č. 8 vybraných přípravků
463
XXXXXXXX VLÁDY
ze xxx 18. xxxxxxxx 2013
o xxxxxxxxx xxxxxxxxxx xxxxx
Xxxxx xxxxxxxx xxxxx §44c xxxx. 1 xxxxxx x. 167/1998 Xx., x návykových látkách x x xxxxx xxxxxxxxx xxxxxxx xxxxxx, xx xxxxx zákona x. 273/2013 Xx.:
§1
Xxxx nařízení stanoví
a) x příloze č. 1 x xxxxxx nařízení xxxxxx
1. xxxxxxxx látek xxxxxxxxxx xx Xxxxxxx X xxxxx Jednotné xxxxxx x xxxxxxxx látkách1) x
2. xxxxxxx xxxxxxxx xxxxx, x nimiž xx z xxxxxx xxxxxxx xxxxxx xxxxxxxxxx xxxxx xxxxx, xx xxxxxxxxxxxxx xxxx nepřímo xxxxxxxx xxxxxx, xxxxxxxx xxxxxxx zacházení jen xx xxxxxxx xxxxxxxx x xxxxxxxxx, xxxx xx x xxxxxx xxxxxx nutné zabezpečit, xxx léčivé přípravky xxxxxxxxxx xxxx xxxxxx xxxxx byly vydávány x xxxxxxx xxxxx xx xxxxxx xxxx xxxxxxx označené modrým xxxxxx směřujícím x xxxxxx dolního xxxx xx xxxxxxx xxxxxxx xxxx,
(xxxx xxx "xxxxxx x. 1 omamných xxxxx"),
x) x příloze č. 2 x xxxxxx xxxxxxxx xxxxxx
1. omamných xxxxx xxxxxxxxxx do Xxxxxxx XX xxxxx Xxxxxxxx xxxxxx o omamných xxxxxxx x
2. xxxxxxx xxxxxxxx látek, x xxxxx xx z xxxxxx xxxxxxx xxxxxx xxxxxxxxxx anebo proto, xx bezprostředně xxxx xxxxxxx xxxxxxxx xxxxxx, xxxxx xxxxxxxxxx, aby xxxxxx xxxxxxxxx xxxxxxxxxx xxxx omamné látky xxxx xxxxxxxx x xxxxxxx xx xxxxxx xxxx xxxxxxx xxx xxxxxxxx modrým xxxxxx,
(xxxx xxx "xxxxxx x. 2 omamných látek"),
c) x příloze č. 3 x xxxxxx xxxxxxxx xxxxxx
1. xxxxxxxx látek xxxxxxxxxx xx Xxxxxxx XX xxxxx Jednotné úmluvy x omamných látkách x
2. dalších xxxxxxxx xxxxx, x xxxxx xx x xxxxxx xxxxxxx jejich xxxxxxxxxx xxxxx proto, že xxxxxxxxxxxxx xxxx nepřímo xxxxxxxx xxxxxx, xxxxx xxxxxxxxxx, xxx látky x přípravky obsahující xxxx omamné xxxxx xxxx xxxxxxxxx xxxxx x xxxxxxxx xxxxxxxxx, xxxxxxxx a velmi xxxxxxxx terapeutickým xxxxxx xxxxxxxxx x xxxxxxxx x xxxxxxxxx,
(xxxx xxx "xxxxxx č. 3 xxxxxxxx xxxxx"),
x) x příloze č. 4 x xxxxxx xxxxxxxx seznam
1. xxxxxxxxxxxxxx xxxxx xxxxxxxxxx xx Xxxxxxx X xxxxx Xxxxxx x xxxxxxxxxxxxxx xxxxxxx2) x
2. xxxxxxx xxxxxxxxxxxxxx xxxxx, u xxxxx xx x xxxxxx xxxxxxx xxxxxx xxxxxxxxxx xxxxx xxxxx, xx bezprostředně xxxx xxxxxxx xxxxxxxx xxxxxx, xxxxx zabezpečit, xxx xxxxx a přípravky xxxxxxxxxx xxxx psychotropní xxxxx byly xxxxxxxxx xxxxx k omezeným xxxxxxxxx, xxxxxxxx x xxxxx xxxxxxxx xxxxxxxxxxxxx xxxxxx xxxxxxxxx x xxxxxxxx x xxxxxxxxx,
(xxxx xxx "xxxxxx x. 4 xxxxxxxxxxxxxx xxxxx"),
x) x příloze č. 5 x xxxxxx nařízení xxxxxx
1. xxxxxxxxxxxxxx látek xxxxxxxxxx xx Xxxxxxx XX xxxxx Xxxxxx x xxxxxxxxxxxxxx xxxxxxx a
2. xxxxxxx psychotropních látek, x nimiž je x xxxxxx xxxxxxx xxxxxx zneužívání xxxxx xxxxx, xx xxxxxxxxxxxxx xxxx xxxxxxx xxxxxxxx xxxxxx, xxxxxxxx xxxxxxx xxxxxxxxx xxx xx xxxxxxx povolení x xxxxxxxxx, xxxx xx x xxxxxx xxxxxx xxxxx zabezpečit, aby xxxxxx xxxxxxxxx xxxxxxxxxx xxxx psychotropní látky xxxx vydávány v xxxxxxx pouze na xxxxxx nebo xxxxxxx xxxxxxxx modrým pruhem xxxxxxxxxx x xxxxxx xxxxxxx xxxx do xxxxxxx xxxxxxx xxxx,
(xxxx xxx "xxxxxx č. 5 xxxxxxxxxxxxxx xxxxx"),
x) x příloze č. 6 x xxxxxx nařízení xxxxxx xxxxxxxxxxxxxx xxxxx xxxxxxxxxx xx Seznamu III xxxxx Xxxxxx x xxxxxxxxxxxxxx látkách,
x) v příloze č. 7 k tomuto xxxxxxxx xxxxxx
1. xxxxxxxxxxxxxx xxxxx xxxxxxxxxx xx Xxxxxxx XX xxxxx Xxxxxx x xxxxxxxxxxxxxx xxxxxxx x
2. xxxxxxx xxxxxxxxxxxxxx xxxxx, u xxxxx je z xxxxxx xxxxxxx xxxxxx xxxxxxxxxx xxxxx proto, xx xxxxxxxxxxxxx nebo xxxxxxx ohrožují zdraví, xxxxx xxxxxxxxxx, xxx xxxxxx přípravky xxxxxxxxxx xxxx xxxxx xxxx xxxxxxxx v lékárně xx xxxxxx nebo xxxxxxx bez označení xxxxxx xxxxxx,
(xxxx jen "xxxxxx x. 7 xxxxxxxxxxxxxx xxxxx"), x
x) x příloze č. 8 x xxxxxx xxxxxxxx xxxxxx xxxxxxxxx xxxxxxxxxx xx Xxxxxxx XXX xxxxx Xxxxxxxx xxxxxx x xxxxxxxx látkách,
(dále xxx "xxxxxx x. 8 xxxxxxxxx xxxxxxxxx").
§2
Xxxx xxxxxxxx xxxx xxxxxxxx x souladu xx směrnicí Xxxxxxxxxx xxxxxxxxxx a Xxxx 98/34/ES xx dne 22. xxxxxx 1998 x postupu xxx xxxxxxxxxxx informací x xxxxxxx norem x xxxxxxxxxxx předpisů x xxxxxxxx xxx xxxxxx xxxxxxxxxx xxxxxxxxxxx, x xxxxxxx znění.
§3
Xxxx nařízení xxxxxx xxxxxxxxx xxxx 1. xxxxx 2014.
Xxxxxxx x. 1 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 1 xxxxxxxx xxxxx
|
Xxxxxxxxxxx nechráněný xxxxx (XXX) x xxxxxx xxxxxx |
Xxxxxxxx název podle XXXXX |
Xxxxxxxx |
|
Xxxxxxxxx |
(5X,6X,7X)-7-[(2X)-2-xxxxxxxxxxxxx-2-xx]-6-xxxxxxx-17-xxxxxx-4,5-xxxxx- 6,14-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
|
XxxxxX-xxxx-xxxxxxxxxxxxxx |
(XX)-X-[1-(2-xxxxX-2-xxxxxxxxxxx)-4-xxxxxxxxx]xxxxxxxxxx |
|
|
XxxxxXxxxxxxxx |
(3XX)-6-(xxxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
|
Xxxxxxxxxxxxxxxxx |
(3X,6X)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
|
Xxxxxxxxxxxx |
(3XX,4Xx)-3-xxxxx-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
|
Xxxxxxxxxxxxx |
(3X,6X)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
|
Xxxx-xxxxxxxxxxxxxx |
X-{1-[(1XX)-2-xxxxx-1-xxxxxxxxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
Xxxx-xxxxxxxxxxxxxxxxxx |
X-{1-[(1XX)-1-xxxxxx-2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
XXxxxxxxxx |
(3X,4XX)-4-xxxxx-1,3-xxxxxxxxxxxxxxxxx-4-xX-xxxxxxxxx |
|
|
Xxxxxxxxxx |
X-{1-[2-(4-xxxxx-5-xxx-4,5-xxxxxxx-1X-xxxxxxxx-1-xx)xxxxx]-4-(xxxxxxxxxxxxx) xxxxxxxxx-4-xx}-X-xxxxxxxxxxxxxxx |
|
|
Xxxxxxxxxxx |
3-xxxxx-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
|
Xxxxxxxxxx |
xxxxx-1-(4-xxxxxxxxxxxxx)-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxxx |
xxxxx-1-[2-(xxxxxxxxx)xxxxx]-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxxxx |
3-(xxxxxxXxxx)-4.5α-xxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx |
|
|
Xxxxxxxxxxxxxxxxxx |
(3X,6X)-6-{xxxxxxxxxxxxx )-4.4-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
|
Xxxx-xxxxxxxxxxxxxxx |
X-{1-[(2XX)-2-xxxxxxxxxxxxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
Xxxx-xxxxxxxxxxxxxxxxxxxxx |
X-{1-[(2XX)-2-xxxxxxxxxxxxxxx]-3-xxxxxxxxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
Xxxxxxxxxxxx |
(3XX,4XX)-3-xxxxx-4-xxxxX-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
|
Xxxxxxxxxxxx |
(3X,6X)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxx |
(3XX,4XX)-4-xxxxx-1,3-xxxxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
|
Xxxxxxxxxx |
2,2-xxxxxxX-4-[4-(2-xxx-3-xxxxxxxxX-2,3-xxxxxxx-1X-xxxxxxxxxxxx-1-xx) xxxxxxxxxx]xxxxxxxxxxx |
|
|
Xxxxxxxxxxxxx |
1-[(3X)-2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxxxxxxxxxx]xxxxxxxxxx |
|
|
Xxxxxxxxxx |
X-[2-(X-xxxxxxxx-X-xxxxxxxxxxx)xxxxxx]xxxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxx |
3-(xxxxxxxxxxxx)-1,1-xx(2-xxxxxxx)xxx-1-xx |
|
|
Xxxxxxxxx |
1-(3,3-xxxxxxx-3-xxxxxxxxxx-4-xxxxxxxxxxxxxx-4-xxxxxxxxxxx xxxxxxxx |
|
|
Xxxxxxxxxxx |
xxxxx-1-(3,3-xxxxxxx-3-xxxxxxxxxx)-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxxxxxx |
(5X,6X,7X)-4,5-xxxxx-7-[(2X)-2-xxxxxxxxxxxxx-2-xx]-6-xxxxxxx-17-xxxxxx- 6,14-xxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxxxx-3,6α-xxxx |
|
|
Xxxxxxxxxxx |
[2-(xxxxxxxxxxxxx)xxxxx)]-2-xxxxxx-2,2-xxxxxxx-xxxxxx |
|
|
Xxxxxxxxxxxx |
6-(xxxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxxxxxxxxx |
X,X,1-xxxxxxxxx-3,3-xx(2-xxxxxxx)xxxxxxxxx |
|
|
Xxxxxxxxxx-xxxxxxx |
xxxxx-2,2-xxxxxxx-4-xxxxxxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxxx |
|
Xxxxxxxxx |
(6XX)-4,4-xxxxxxx-6-xxxxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxx |
(6X)-3,4-xxxxxxxxx-17-xxxxxxxxxxxxxx-6β,14-xxxx |
|
|
Xxxxxxx |
xxxxxxxx (1X,2X,3X,5X)-3-xxxxxxx-8-xxxxxx-9-xxxxxxxxxx[3.2.1]xxxxx-2-xxxxxxxxxxx, xxxx xxxxxx x xxxxxxxx, x xxxxxxx xx xxxxx získat ekgonin x kokain |
|
|
Ethylmethylthiambuten |
N-ethyl-N,1-dimethyl-3,3-bis(2-thienyl)-2-propenylamin |
|
|
Etonitazen |
1-[2-(deethylamino)ethyl]-2-(4-ethoxybenzyl]-5-nitro-1H-benzimidazol |
|
|
Etoxeridin |
ethyl-4-fenyl-1-[2-(2-hydroxyethoxy)ethyl]piperidin-4-karboxylát |
|
|
Fenadaxon |
4,4-difenyl-6-morfolinoheptan-3-on |
|
|
Fenampromid |
N-(1-methyl-2-piperidinoethyl)propananilid |
|
|
Fenazocin |
(2RS,6R,11R)-3-fenethyl-6,11-dimethyl-1,2,3,4,5,6-hexahydro-2,6-methano- 3-xxxxxxxxxx-8-xx |
|
|
Xxxxxxxxxx |
17-xxxxxxxXxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxx |
xxxxx-4-xxxxx-1-(3-xxxxxxxxxxx)-3-xxxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxx |
X-(1-xxxxxxxxxxxxxxxxx-4-xx)-X-xxxxxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
xxxxX-4-xxxxX-1-[2-(xxxxxxxxxxx)xxxxx]xxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxXxxxxxxxx-6-xx |
|
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxxxx-3,6α,14-xxxxx |
|
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxxx-6-xx |
|
|
Xxxxxxxxxxxxxxx |
xxxxx-4-(3-xxxxxxxxxxxx)-1-xxxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
xxxxxxxxxxx |
6-(xxxxxxxxxxxxx)-4,4-xxxxxxx-5-xxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxx |
xxxxxx-1-xxxxxxxx-4-(X-xxxxxxxxxxxxxxxx)xxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxx |
2-(4-xxxxxxxxxxx)-1-[2-(xxxxxxxxxxxxx)xxxxx]-5-xxxxx-1X-xxxxxxxxxxxx |
|
|
Xxxxxxx |
xxxxxxxx 2-{[X-(4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxxx-6-xxxxxx) amino]oxy}octová |
|
|
Koka - xxxx |
Xxxxxx list |
|
|
Kokain |
(1R,2R,3S,5S)-3-(benzoyloxy)-8-methyl-8-azabicyklo[3.2.1]oktan-2- xxxxxxxxxx |
|
|
Xxxxxxxxxx x xxxxxxxx |
Xxxxxxxxxxx x xxxxxx xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx xxxxxxx makoviny |
|
|
Konopí xxxxxxx x xxxxxxxx |
Xxxxxxx x xxxxxxxx x xxxxxx |
|
|
Xxxxxx xxx xxxxxxx xxxxxxx |
xxxxxx určené x xxxxxxxx xxxxxxxx přípravků xx xxxxxxxxxxxxxxxx obsahem xxxxxxxxxxxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxx |
1-xxxxx-2-[(9X,13X,14X)3-xxxxxxxxxxxxxxx-17-xx]xxxxx-1-xx |
|
|
Xxxxxxxxxxxxx |
(9X,13X,14X)-3-xxxxxxxx-17-xxxxxxxxxxxxxx |
Xxxxxxxxxxxxxx xxxxxxxxxxxxxxx [(+)-3-xxxxxxx-17- xxxxxxxxxxxxxx] je xxxxx xx seznamu xxxxxxxx xxxxx xxxxxxxxx x xxxx xxxxxxx |
|
Xxxxxxxxxxx |
(3X)-2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxx-1-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
|
Xxxxxxxxxx |
(9X,13X,14X)-17-xxxxxxxxxxxxxx-3-xx |
Xxxxxxxxxxxxxx xxxxxxxxxxx [(+)-3-xxxxxxx-17- xxxxxxxxxxxxxx] je xxxxx ze xxxxxxx xxxxxxxx látek uvedených x této xxxxxxx |
|
Xxxxxxxxx |
(2X,6X,11X)-3,6,11-xxxxxxxxx-1,2,3,4,5,6-xxxxxxxxx-2,6-xxxxxxxxx-3- xxxxxxxxx-8-xx |
|
|
Xxxxxxxx |
(6XX)-6-(xxxxxxxxxxxxx)4,4-xxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxx, xxxxxxxxxxx |
4-(xxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxx |
4,5α-xxxxx-6,17-xxxxxxxxxxxxxx-6-xx-3-xx |
|
|
Xxxxxxxxxxxxxxxxxxx |
4,5-xxxxx-6,17-xxxxxxxxxxxxxxxx-3,6-xxxx |
|
|
Xxxxxxx |
4,5-xxxxx-3-xxxxxxx-5,17-xxxxxxxxxxxxxxxx-6-xx |
|
|
Xxxxxxx, xxxxxxxxxxx |
2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxxxxxxxxxxx xxxxxxxx |
|
|
Xxxxxxxxxxxxxx |
X-(1-xxxxxxxx-3-xxxxxxxxxxxxxxx-4-xx)xxxxxxxxxxxx |
3-Xxxxxxxxxxxxxx |
|
Xxxxxxxxxxxxxxxxxx |
X-{(3XX)-3-xxxxxx-1-[2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
3-xxxxxxxxxxxxxxxxxx |
|
Xxxxxxxxxx |
xxxxx-4-xxxxx-1-(3-xxxxxxxxxxxxxx)xxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxx |
4,5α-xxxxx-17-xxxxxXxxxxxx-7-xx-3,6α-xxxx |
|
|
Xxxxxx xxxxxxxxxxx |
4,5α-xxxxx-3,6α-xxxxxxxxx-17,17-xxxxxxxxxxxxxx-7-xx-17-xxx-xxxxxx |
x xxxx xxxxxxxx xxxxxxx se xxxxxxxxxx xxxxxxx xxxxxx xxxxxxxx xxxxxx-X-xxxxx (i xxxxxx-X-xxxxx) |
|
Xxxxxx-X-xxxx |
4,5α -xxxxx-17-xxxxxxxxxxxx-7-xx-3,6α-xxxx-17-xxxx |
|
|
XxxxxxxxXxxxxxx |
4-xxxxx-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
XXXX |
|
Xxxxxxx |
3-(xxxxxxxxx)-4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-6-xx-xxxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-3,6α-xxxx-xxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxx |
4,4-xxxxxxx-6-(xxxxxxxxxxx)xxxxxx-3-xx-xxxxxx |
|
|
Xxxxxxxxxxxxx |
(9X,13X,14X)-xxxxxxxx-3-xx |
|
|
Xxxxxxxxxxx |
6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxx |
4,5α-xxxxxxxxxxx-7-xx-3,6α-xxxX |
|
|
Xxxxxxxxxx |
4,4-xxxxxxx-6-xxxxxxxxxxxxxxx-3-xx |
|
|
Xxxxx |
Xxxxx xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx, xxxxxxx xxxxxx ředění xx xxxxx xxx X4 xxxx XX2 |
|
|
Xxxxxxxx |
4,5α-xxxxx-6-xxxxxxx-17-xxxxxxxxxxxxx-6,8(14)-xxxx-3-xx |
|
|
Xxxxxxxx |
(5X)-4,5-xxxxx-14-xxxxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6-xx |
|
|
Xxxxxxxxx |
(5X)-4,5-xxxxx-3,14-xxxxxxxxx-17-xxxxxxxxxxxxxx-6-xx |
|
|
Xxxxxxxxxxxxxxxxx |
X-(1-xxxxxxxXxxxxxxxxx-4-xx)-4'-xxxxxxxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
xxxxx-1-xxxxxxxx-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
XXXXX |
|
Xxxxxxxx |
xxxxx-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxx, xxxxxxxxxxx X |
4-xxxxx-1-xxxxxxxxxxxxxxx-1-xxxxxxxxxxx |
|
|
Xxxxxxxx, meziprodukt B |
ethyl-4-fenylpiperidin-4-karboxylát |
|
|
Pethidin, xxxxxxxxxxx C |
kyselina 4-xxxxx-1-xxxxxxxxxxxxxxx-4-xxxxxxxxxxx |
|
|
Xxxxxxxxx |
xxxxx-1-(3-xxxxxxxxxxxxx)-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxx |
1'-(3,3-xxxxxxx-3-xxxxxxxxxx-4'-xxxxxx-1,4'-xxxxxxxxxxx |
|
|
Xxxxxxxxxxx |
4-xxxxx-1,3-xxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
|
Xxxxxxxxxx |
xxxxxxxxX-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxxxxx |
(9XX,13XX,14XX)-3-xxxxxxx-17-xxxxxxxxxxxxxx |
|
|
Xxxxxxxxxxxx |
(3XX)-2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxx-1-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
|
Xxxxxxxxxx |
(9XX,13XX,14XX)-17-xxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxxxx |
xxxxxx-3-[4-(X-xxxxxxxxxxxxxxx)4-(xxxxxxxxxxxxxxx)]xxxxxxxxxx]xxxxxxxxx |
|
|
Xxxxxxxxxx |
X-{4-(xxxxxxxxxxxxx)-1-[2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
3-[(1X,2X)-3-(xxxxxxxxxxxxx)-1-xxxxx-2-xxxxxxxxxxxx]xxxxx |
|
|
Xxxxxxx |
4,5α-xxxxx-3,6-xxxxxxxxx-17-xxxxxxxxxxxxxxx-6,8-xxxx |
|
|
Xxxxxxxx |
(5X)-4,5-xxxxx-3-xxxxxxx-17-xxxxxXxxxxxx-6-xx-6-xx-xxxxxx |
|
|
Xxxxxxxxxxxx |
X-{1-[2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
Xxxxxxx |
xxxxx-(1XX,2XX)-2-(xxxxxxxxxxxxx)-1-xxxxxxxxxxxxx-3-xx-1-xxxxxxxxxx |
|
|
Xxxxxxxxxxxx |
(XX)-4-xxxxx-4-(1,2,5-xxxxxxxxxxxxxxxxxx-4-xx)xxxxxxxxx |
Xxxxxx xxxxxxx omamných xxxxx xxxxxxxxx x xxxxx xxxxxxx, xxxx xxxxxx x xxxxxx xxxxxxxx xxxxx uvedených x xxxxx seznamu x xxxx xxxxxxxx látek xxxxxxxxx x xxxxx xxxxxxx xxxxxx solí xxxxxxx, xxxxxx a xxxxx xx xxxxx xxxxxxxxx, kdy xxxx xxxx xxxxx xxxxxxxxx.
Příloha x. 2 x nařízení xxxxx x. 463/2013 Xx.
Xxxxxx x. 2 omamných xxxxx
|
Xxxxxxxxxxx nechráněný xxxxx (XXX) v českém xxxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx-xxxxxx |
|
|
Xxxxxxxxxxxxxxxx |
(1X,2X)-1-xxxxxx-3-(xxxxxxxxxxxxx)-1-xxxxxxxxxxxx-xxxxxxxxx |
|
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx |
|
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx |
|
|
Xxxxxxxx |
4,5α-xxxxx-17-xxxxxx-3-(2-xxxxxxxxxxxxxxx)xxxxxx-7-xx-6α-xx |
|
|
Xxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx |
|
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx-xxxxxxxxx |
|
|
Xxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxx--7-xx-6-xx-xxxxxxxxx |
|
|
Xxxxxxxxx |
4,5α-xxxxx-3-xxxxxxxxxxxxx-7-xx-6α-xx |
|
|
Xxxxxxxx |
X-[(1XX)-1-xxxxxx-2-xxxxxxxxxxxxxxx]-X-(2-xxxxxxx)xxxxxxxxxx |
Xxxxxx xxxxxxx xxxxxxxx xxxxx xxxxxxxxx x xxxxx seznamu, xxxx xxxx omamných xxxxx xxxxxxxxx x xxxxx xxxxxxx, xxxxxx xxxx xxxxxxx xxxxx xxxxxxxxx x tomto seznamu xx xxxxx případech, xxx tyto xxxx xxxxx xxxxxxxxx.
Příloha č. 3 x xxxxxxxx vlády x. 463/2013 Sb.
Seznam x. 3 xxxxxxxx xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx název (XXX) x xxxxxx xxxxxx |
Xxxxxxxx xxxxx podle XXXXX |
Xxxxxxxx |
|
Xxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxx |
[5X,6X,7X,14X)-4,5-xxxxx-7-[(2X)-2-xxxxxxxxxxxxx-2-xx]-6-xxxxxxx- 17-xxxxxx-6,14-xxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxx |
(5X,6X)-4,5-xxxxx-17-xxxxxxxxxxxx-7-xx-3,6-xxxx-xxxxxxxx |
|
|
Xxxxxxxxxxx |
1-[4-(3-xxxxxxxxxxxx)-1-xxxxxxxxxxxxxxx-4-xx]xxxxxx-1-xx |
|
|
Xxxxxx |
X xxxxxxxx xxxxxx xxx léčebné xxxxxxx xxxxxxx x xxxxxxx x. 1 |
|
|
Xxxxxxxxxx x xxxxxx |
Xxxxxx xxxx xxxxxxxx látek uvedených x xxxx xxxxxxx xx xxxxx xxxxxxxxx, xxx tyto xxxx xxxxx xxxxxxxxx.
Xxxxxxx x. 4 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 4 xxxxxxxxxxxxxx xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) x xxxxxx xxxxxx |
Xxxxx mezinárodní nechráněný xxxxx xxxx xxxxxx xxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
|
XX-7921 |
3,4-xxxxxxx-X-{[1-(xxxxxxxxxxxxx)xxxxxxxxxx)]xxxxxx}xxxxxxxx |
||
|
XX-2201 |
[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx](xxxxxxxx-1-xx)xxxxxxxx |
||
|
5-XX1 |
5-(2-xxxxxxxxxxx)xxxxx |
||
|
XXXXXXX |
X-(xxxxxxxxx-1-xx)-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
xx-XXX |
2-xxxxx-1-(4-xxxxxxxxxxxx)xxxxxx-1-xx |
||
|
xx-XXXX |
1-(4-xxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
||
|
25X-XXXXx |
2-(4-xxxx-2,5-xxxxxxxxxxxxxx)-X-[(2-xxxxxxxxxxxx)xxxxxx]xxxxxxxxx |
||
|
Xxxxxxxxxxxxx |
XXX |
(2XX)-1-(4-xxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxx-Xxxxxxxxx |
1-(8-xxxxxxxxx[1,2x:4,5-x´]xxxxxxx-4-xx)xxxxxx-2-xxxx |
||
|
Xxxxxxx |
2-(xxxxxxxxxxx)-1-[3,4-(xxxxxxxxxxxxx)xxxxx)]xxxxx-1-xx |
||
|
Xxxxxxxxxxxxxxxxxxxxxxxx |
2X-X |
(4-xxx-2,5-xxxxxxxxxxxxxxxxx)xxxx |
|
|
25X-XXXXx |
2-(4-xxxxx-2,5-xxxxxxxxxxxxxx)-X-[(2-xxxxxxxxxxxx)xxxxxx]xxxxxxxxx |
||
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
2X-X-2 |
[4-(xxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx]xxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
2X-X-7 |
[2,5-xxxxxxxxx-4-(xxxxxxxxXxxxxx)xxxxxxxx]xxxx |
|
|
XX-47,497 |
2-[(1X,3X)-3-xxxxxxxxxxxxxxxxx]-5-(2-xxxxxxxxxxx-2-xx)xxxxx |
||
|
XXX-13 |
(xxxxxxxx-1-xx)[4-(xxxxxxxxx)xxxxxxxx-1-xx]xxxxxxxx |
||
|
XXXX |
1,4-xxxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxxx |
XXX |
X,X-xxxxxxx-X-[2-(xxxxx-3-xx)xxxxx]xxxx |
|
|
Xxxxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
4,4'-XXXX |
4-xxxxxx-5-(4-xxxxxxxxxxx)-4,5-xxxxxxx-1,3-xxxxxx-2-xxxx |
||
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
XXXX |
3-(1,2-xxxxxxxxxxxxxx)-6,6,9-xxxxxxxxx-7,8,9,10-xxxxxxxxxx-6X-xxxxx[x] xxxxxxx-1-xx |
|
|
3,4-XXXX |
1-(3,4-xxxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
||
|
Xxxxxxxxxxxxxxxxx |
XXX |
X[2-(xxxxx-3-xx (xxxxx]-X,X-xxxxxxxxxxxx |
|
|
XXX |
1-(4-xxxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
||
|
Xxxxxxxxxxxxxxxxxxxxxxx |
XXXX |
(2XX)-1-(4-xxxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
XXx |
1-(4-xxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
||
|
Xxxxxxxxxxx |
XXX |
X-xxxxx-1-xxxxxxxxxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
3-(2-xxxxxxxxxx)xxxxx |
||
|
4-XX |
1-(4-xxxxxxxxxx)xxxxxx-2-xxxx |
||
|
5X-XXX48 |
X-(xxxxxxxxx-1-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
Xxxxxxxxx |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
||
|
4-XXX |
1-(4-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
||
|
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
||
|
5XXX-144 |
[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx](2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
||
|
251-XXXXx |
2-(4-xxx-2,5-xxxxxxxxxxxxxx)-X-[(2-xxxxxxxxxxxx)xxxxxx]xxxxxxxxx |
||
|
XXX-018 |
(xxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
|
XXX-073 |
(1-xxxxx-1X-xxxxx-3-xx)(xxxxxxxx-1-xx)xxxxxxxx |
||
|
XXX-081 |
(4-xxxxxxxxxxxxxxx-1-xx)(1 -xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
|
XXX-122 |
(4-xxxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-x)xxxxxxxx |
||
|
XXX-200 |
[1-(2-xxxxxxxxxxxxxx)-1X-xxxxx-3-xx](xxxxxxxx-1-xx)xxxxxxxx |
||
|
XXX-250 |
2-(2-xxxxxxxxxxxx)-1-(1-xxxxxx-1X-xxxxx-3-xx)xxxxx-1-xx |
||
|
XXX-398 |
(4-xxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
|
Xxxxxxxx |
(2X)-2-xxxxx-1-xxxxxxxxxxx-1-xx |
||
|
(+)-Xxxxxxxx |
XXX, LSD-25 |
(+)-8β-(3,3-dinethylureido)-6-methyl-9,10-didehydroergolin |
|
|
4-Metamfetamin |
(2RS)-1-(4-methylfenyl)propan-2-amin |
||
|
MBZP |
1-benzyl-4-methylpiperazin |
||
|
mCPP |
1-(3-chlorfenyl)piperazin |
||
|
MDAI |
5,6-(methylendioxy)indan-2-amin |
||
|
MDPV |
1-[3,4-(methylendioxy)fenyl]-2-(pyrrolidin-1-yl)pentan-1-on |
||
|
3-MEC |
2-(ethylamino)-1-(3-methylfenyl)propan-1-on |
||
|
4-MEC |
2-(ethylamino)-1-(4-methylfenyl)-propan-1-on |
||
|
Mefedron |
2-(methylamino)-1-(4-methylfenyl)propan-1-on |
||
|
Meskalin |
3,4,5-trimetlioxyfenethylamin |
||
|
Methkathinon |
Efedron |
(2RS)-1-fenyl-2-(methylamino)propan-1-on |
|
|
3-MMC |
2-(methylamino(-1-(3-methyIfenyl)propan-1-on |
||
|
Methoxytenamfetamin |
MMDA |
(2RS)-1-[5-methoxy-3,4-(methylendioxy)fenyl]propan-2-amin |
|
|
Methylaminorex |
(±)-5-fenyl-4-methyl-4,5-dihydrooxazol-2-aminn |
||
|
Methyltenamfetamin |
MDMA |
(2RS)-N-methyl-1-[3,4-(methylendioxy)fenyl]propan-2-amin |
|
|
3-MeO-PCP |
1-[1-(3-metlioxyfenyl)cyklohexyl]piperidin |
||
|
methoxetamine |
2-(ethylamino)-2-(3-methoxyfenyl)cyclohexanon |
||
|
Methylon |
2-(methylamino)-1-[3,4-(methylendioxy)fenyl]propan-1-on |
||
|
MT-45 |
1-cyklohexyl-4-(1,2-difenylethyl)-piperazin |
||
|
Methylthioamfetamin |
4-MTA |
(2RS)-1-[4-(methyIsulfanyl)fenyl]propan-2-amin |
|
|
Nafyron |
1-(naftalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-on |
||
|
Ethyltenamfetamin |
MDE, XXXX |
(2XX)-X-xxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxxxxxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxx |
(2XX)-X-xxxxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx|xxxxxx-2-xxxx |
||
|
Xxxxxxxxxx |
3-xxxxx-6,6,9-xxxxxxxxx-7,8,9,10-xxxxxxxxxx-6X-xxxxx[x]xxxxxxx-1-xx |
||
|
xxxxxxxxx |
1-xxxxx-2-(xxxxxxxxxxxx)xxxxxx-1-xx |
||
|
xXXX |
1-(4-xxxxxxxxxx)xxxxxxxxx |
||
|
Xxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(4-xxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxx |
XXXX |
1-(4-xxxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
Xxxxxxxxxx |
3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx-xxxxxxxxxx-xxxxxx |
||
|
Xxxxxxxx |
Xxxxxxxxx |
3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx |
|
|
Xxxxxxxxxxxx |
XXX, XXXX |
1-(1-xxxxxxxxxxxxxxx)xxxxxxxxxx |
|
|
α-XXX |
1-xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxxx-1-xx |
||
|
Xxxxxxxxxx A |
methyl-(2RS,4aR,6aR,7R,9RS,10aRS,10bR)-9-acetoxy-2-(furan-3-yl)-6a, 10b-dimethyl-4,10-dioxododekahydro-1H-benzo[f]isochromen-7-karboxylát |
||
|
Dimethoxymetamfetamin |
STP, XXX |
(2XX)-1-(2,5-xxxxxxxxx-4-xxxxxxxxxxx]xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxx |
XXX |
(2XX)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxx |
XXX |
1-[1-(2-xxxxxxx)xxxxxxxxxx]xxxxxxxxx |
|
|
XXXXX |
1-[3-(xxxxxxxxxxxxxx)xxxxx]xxxxxxxxx |
||
|
Xxxxxxxxxxxxxxxxxxx |
XXX |
Δ6x(10x)-,Δ6x(7)-,Δ7-,Δ8-,Δ10-,Δ9(11)-xxxxxxxxxxxxxxxxxxxx a xxxxxx xxxxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(3,4,5-xxxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxx-2 |
XXX-2 |
(2XX)-1-(2,4,5-xxxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
XX-144 |
(1-xxxxxx-1X-xxxxx-3-xx)-(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
Xxxxxx xxxxxxxxxxxxx xxxxxxxxxxxxxx xxxxx, xx xx xxxxxxxx xxxxxxx, xxxxxxxxx x xxxxx xxxxxxx xx všech případech, xxx xxxx xxxxxxxxxxxxx xxxxx xxxxxxxxx xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxxxx x xxxx psychotropních xxxxx uvedených v xxxxx seznamu ve xxxxx xxxxxxxxx, xxx xxxxx existovat.
Xxxxxxx č. 5 x xxxxxxxx vlády x. 463/2013 Xx.
Xxxxxx x. 5 psychotropních xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) x xxxxxx xxxxxx |
Xxxxx xxxxxxxxxxx xxxxxxxxxx xxxxx xxxx xxxxxx xxxxx |
Xxxxxxxx xxxxx podle XXXXX |
Xxxxxxxx |
|
Xxxxxxxxx |
(2XX)-1-xxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxxxx |
xxxxxxxx 7-[(10,11-xxxxxxx-5X-xxxxxxx[x,x][7]xxxxxxx-5-xx) xxxxx]xxxxxxxxx |
||
|
Xxxxxxxxxx |
(2X)-2-[(5X,6X,7X,14X)-17-(xxxxxxxxxxxxxxxxx)-4,5α-xxxxx-3- xxxxxxx-6-xxxxxxx-6α,14-xxxxxxxxxxxxxx-7x-xx]-3,3-xxxxxxxx butan-2-ol |
||
|
Bromdimethoxyfenethyl xxxx |
2X-X |
(4-xxxx-2,5-xxxxxxxxxxxxxxxxx)xxxx |
|
|
Xxxxxxxxxxxx |
(2X)-1-xxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxxxxx |
XXX |
1-(1-xxxxxxxxxxxxxxx)xxxxxxxxx |
|
|
Xxxxxxxxx |
7-(2-{[(2XX)-1-xxxxxxxxxxx-2-xx]xxxxx}xxxxx)-1,3-xxxxxxxx-7X- xxxxx-2,6-xxxx |
||
|
Xxxxxxxxxxx |
2-xxxxX-3-xxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxxx |
5-(2-xxxxxxxxxx)-1-xxxxxx-7-xxxxx-1X-1,4-xxxxxxxxxxxxx-2(3X)-xx |
||
|
XXX |
xxxxxxxx 4-xxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxx |
(2XX)-1-xxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxxxxxxxxx |
(2XX)-1-xxxxx-X-xxxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxxxxx |
3-(2-xxxxxxxxxx)-2-xxxxxx-1,2-xxxxxxxxxxxxxxxxx-4(3X)-xx |
||
|
Xxxxxxxxxx |
2-xxxxxxx-3-(2-xxxxxxxxxxx)-1,2-xxxxxxxxxxxxxxxxx-4(3X)-xx |
||
|
Xxxxxxxxxxxx |
(2X)-1-xxxxx-X-xxxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxxxxxx racemický |
(2RS)-1-fenyl-N-methylpropan-2-amin |
||
|
Methylfenidát |
methyl-(2RS)-2-fenyl-2-[(2RS)-piperidin-2-yl]acetát |
||
|
Sekobarbital |
kyselina 5-xxxxx-5-(1-xxxxxxxxxxx)xxxxxxxxxxx |
||
|
Xxxxxxxxxx |
xxxxx-9-XXX |
Δ9-xxxxxxxxxxxxxxxxxxx (THC) a xxxx stereoizomery |
např. (-)-trans-Δ9-THC |
|
Zipeprol |
(2RS)-1-fenyl-1-methoxy-3-[4-(2-methoxyfenethyl)piperazin-1-yl] xxxxxx-2xx |
Xxxxxx xxxx xxxxx xxxxxxxxx x xxxx xxxxxxx xx xxxxx xxxxxxxxx, kdy existence xxxxxxxx xxxx xx xxxxx.
Příloha x. 6 x xxxxxxxx xxxxx x. 463/2013 Sb.
Seznam x. 6 psychotropních xxxxx
|
Xxxxxxxxxxx nechráněný xxxxx (XXX) x xxxxxx xxxxxx |
Xxxxx xxxxxxxxxxx xxxxxxxxxx xxxxx nebo obecný xxxxx |
Xxxxxxxx název xxxxx XXXXX |
Xxxxxxxx |
|
Xxxxxxxxxxx |
xxxxxxxx 5-ethyl-5-isopentylbarbiturová |
||
|
Butalbital |
kyselina 5-xxxxx-5-xxxxxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxxx |
xxxxxxxx 5-(1-xxxxxxxx-1-xx-1-xx)-5-xxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxx |
(3XX)-3-xxxxx-3-xxxxxxxxxxxxxx-2,6-xxxx |
||
|
Xxxxxx |
(+)-xxxxxxxxxxxxxxxx |
(1X,2X)-2-xxxxx-1-xxxxxxxxxxx-1-xx |
|
|
Xxxxxxxxxxx |
(2X,6X,11X)-6,11-xxxxxxxx-3-(3-xxxxxxxxx-2-xx-1-xx)-1,2,3,4,5,6- xxxxxxxxx-2,6-xxxxxxx-3-xxxxxxxxxx-8-xx |
||
|
Xxxxxxxxxxxxx |
xxxxxxxx 5-ethyl-5[(1RS)-1-methylbutyl]barbiturorá |
Včetně xxxx látek xxxxxxxxx x xxxx xxxxxxx xx všech xxxxxxxxx, xxx xxxxxxxxx xxxxxxxx xxxx je xxxxx.
Xxxxxxx x. 7 x nařízení xxxxx x. 463/2013 Xx.
Xxxxxx x. 7 xxxxxxxxxxxxxx xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx název (XXX) v xxxxxx xxxxxx |
Xxxxx xxxxxxxxxxx xxxxxxxxxx xxxxx nebo xxxxxx xxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
|
Xxxxxxxxxxxx |
5,5-xxxxxxxxxxxxxxxxxx kyselina |
||
|
Alprazolam |
8-chlor-6-fenyl-1-methyl-4H.[1,2,4]triazolo[4,3-a][1,4]benzodiazepin |
||
|
Amfepramon |
2-(diethylamino)-1-fenylpropan-1-on |
||
|
Aminorex |
5-fenyl-4,5-dihydrooxazol-2-amin |
||
|
Barbital |
5,5-diethylbarbiturová xxxxxxxx |
||
|
Xxxxxxxxxxx |
(+)-X-xxxxxx-X-(2-xxxxx-1-xxxxxxxxxxx)-X-xxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxx |
1-xxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxx |
7-xxxx-5.(2-xxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
2-xxxx-4-(2-xxxxxxxxxx)-9-xxxxxx-6X-xxxxxx[3,2-x][1,2,4]xxxxxxxx[4,3-x]xxxxxxxx |
||
|
Xxxxxxxxxxxx |
5-xxxxx-5-xxxxxxxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxx-2xx |
||
|
Xxxxxxxxx |
8-xxxxx-6-xxxxx-4X-[1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx |
||
|
Xxxxxxxxx |
X-(1-xxxxxxxxxxxxxxxxxx)xxxxxxxx |
||
|
Xxxxxxxxxxxxx |
1-xxxxx-3-xxxxxxxxx-1-xx-4-xx-3-xx |
||
|
Xxxxxxxxxxxxxx |
(±)-2-(xxxxxxxxxx)-1-xxxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxx |
xxxxx-7-xxxxx-5-(2-xxxxxxxxxx)-2-xxx-2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx-3- xxxxxxxxxx |
||
|
Xxxxxxxxxxxxx |
(2X,3X)-2-xxxxx-3,4-xxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxx |
(±)-2-(xxxxxxxxxx)-3-xxxxxxxxxxxx[2.2.1]xxxxxx |
||
|
Xxxxxxxxxxxx |
5-xxxxx-5-xxxxxxxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxxxx |
(±)-1-xxxxx-2-[(2-xxxxxxxxx)xxxxx]xxxxxx |
||
|
Xxxxxxxx |
2-xxxxx-1,1-xxxxxxxxxxxxxxxxx |
||
|
XXxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
XXxxxxxxxxx |
7-xxxxx-2-[2-(xxxxxxxxxxxx)xxxxx]-5-(2-xxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxx- 2-xx |
||
|
Xxxxxxxxx |
7-xxxxx-5-xxxxx-1-(2,2,2-xxxxxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxxx |
10-xxxx-11x-(2-xxxxxxxxxx)-2,3,7,11x-xxxxxxxxxxxxxxxxx[3,2-x][1,4]xxxxxxxxxxxxx -6(5X)-xx |
||
|
Xxxxxxxxxxxxxxxx |
7-xxxxx-5-xxxxx-2-(xxxxxxxxxxx)-3X-1,4-xxxxxxxxxxxxx-4-xxxx |
||
|
Xxxxxxxxx |
7-xxXxx-5-xxxxx-1-xxxxxx-2-xxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-3-xx-xxxxxxxx xxxxxxxx |
||
|
Xxxxxxx |
(2XX)-2-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxxxxxx-1-xx |
||
|
Xxxxxxxxx |
11-xxxxx-12x-xxxxx-2,8-xxxxxxxx-8,12x-xxxxxxx-4X-[1,3]xxxxxxx[3,2-x][1,4] xxxxxxxxxxxx-4,7(6X)-xxxx |
||
|
Xxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-1X-1,5-xxxxxxxxxxxx-2,4(3X,5X]-xxxx |
||
|
Xxxxxxxxxx |
5-{2-xxxxxxxxxX}-7-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
7-xxxxx-5-xxxxx-2-xxx--2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx-3-xxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxxxxx |
5-(2-xxxxxxxxxx)-7-xxxxx-1-xxxxxx-1,3-xxxxxxx-2X-xxxxxx[2,3-x][1,4]xxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
10-xxxxx-11x-(2-xxxxxxxxxx)-2,3,7,11x-xxxxxxxxxxxxxxxxx[3,2-x][1,4] benzodiazepin-6(5H)-on |
||
|
Lefetamin |
SPA |
(-)-1-(dimethylamono)-1,2-difenylethan |
|
|
Loprazolam |
3-(2-chlorfenyl)-2-[(4-methylpiperazin-1-yl)methyl]-8-nitro-2,4-dihydro-1H- xxxxxxxx[1,2-x][1,4]xxxxxxxxxxxxx-1-xx |
||
|
Xxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-3-xxxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-3-xxxxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2 -xx |
||
|
Xxxxxxxx |
5-(4-xxxxxxxxxx)-2,5-xxxxxxx-3X-xxxxxxx[2,1-α]-xxxxxxxx-5-xx |
||
|
Xxxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx |
||
|
Xxxxxxxxx |
(±)-2-[(3-xxxxxxxxxxx)xxxxx]-1-xxxxxxxxxxx |
||
|
Xxxxxxxxxx |
2-xxxxxx-2-xxxxxxxxxxxx-1,3-xxxx-xxxxxxxxxx |
||
|
Xxxxxxxx |
X-(xxxxxxxxxxxxxx)-3-(2-xxxxx-1-xxxxxxxxxxx)xxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxxxxx |
5-xxxxx-5-xxxxx-1-xxxxxxxxxxxxxxxxx kyselina |
||
|
Methyprylon |
3,3-diethyl-5-methylpiperidin-2,4-dion |
||
|
Midazolam |
8-chlor-6-(2-fluorfenyl)-1-methyl-4H-imidazol[1,5-α][1,4]bezodiazepin |
||
|
Nimetazepam |
5-fenyI-1-methyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
Nitrazepam |
5-fenyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
Nordazepam |
7-chlor-5-fenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
Oxazepalll |
7-chlor-5-fenyl-3-hydroxy-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
Oxazalant |
10-chlor-11b-fenyl-2-methyl-2,3,7,11b-tetrahydroozazolo[3,2-d][1,4] xxxxxxxxxxxxx-6(5X)-xx |
||
|
Xxxxxxx |
5-xxxxX-2-xxxxx-1,3 -xxxxxxxxxx-4-xx |
||
|
Xxxxxxxxx |
7-xxxxxx-4-xxxxx-1-(xxxx-2-xx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxx |
xxxxxxX(2-xxxxxxxxx)xxxxxxxx |
||
|
Xxxxxxxx |
7-xxxxx-1-(xxxxxxxxxxxxxxxxx)-5-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxxx |
(±)-1-(4-xxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
||
|
Xxxxxxxxxxxxxxx |
5-xxxxx-5-(1-xxxxxxxxxxxxxxxx)xxxxxxxxxxx kyselina |
||
|
Temazepam |
(RS)-7-chlor-5-fenyl-3-hydroxy-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
Tetrazepam |
7-chlor-5-(cyklohex-1-en-1-yl)-1-methyl-1,3-dihydro-2H-1,4-bezodiazepin-2-on |
||
|
Triazolamn |
8-chlor-6-(2-chlorfenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-α][1,4]benzodiazepin |
||
|
Vinylbital |
5-(1-methylbutyl)-5-vinylbarbiturová xxxxxxxx |
||
|
Xxxxxxxx |
X,X,6-xxxxxxxxx-2-(4-xxxxxxxxxxx)xxxxxxxx[1,2-α]xxxxxxx-3-xxxxxxxx |
Xxxxxx xxxx látek xxxxxxxxx v této xxxxxxx xx všech xxxxxxxxx, xxx xxxxxxxxx xxxxxxxx xxxx xx xxxxx.
Xxxxxxx x. 8 x xxxxxxxx vlády x. 463/2013 Xx.
Xxxxxx x. 8 xxxxxxxxx xxxxxxxxx
|
Xxxxxxxxx xxxxxxxxxx: |
Xxxxxxxx: |
||
|
1) |
xxxxx x xxxxxxxx xxxxx: xxxxxxxxxxxxxxxxxxx xxxxxxxxxxxxx xxxxXxxxxxx xxxxxxxx xxxxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxxx |
Xxxxx xxxxxxxxx xxxxx nebo více xxxxxxx látek (nikoliv xxxx xxxxxxxx) x xxxxxxxx xxxxxx xxxxx |
|
|
x) |
x xxxxx tabletě, xxxxxxx, xxxxxx, čípku, xxxx. x xxxx xxxxxx xxxxx xxxxx přesáhnout 100 mg, |
||
|
b) |
v xxxxxxx xxxxx xxx xxxxxxxxxxx xxxxx xxx 2,5 % |
||
|
2) |
xxxxxxxxx |
x) |
Xxxxxxxx difenoxinu xxxxx xxxxxxxxxx x xxxxx xxxxxxx, xxxxxxx, xxxxxx, xxxxx, xxxx. x xxxx xxxxxx xxxxx 0,5 xx. |
|
x) |
Xxxxxxxx xxxxxxx-xxxxxxx xxxx xxx nejméně 5 % x xxxxxxxx xxxxxxxxxxxx x xxxxx tabletě, xxxxxx, xxxxxx, xxxxx, popř. xxxx xxxxxx xxxxx. |
||
|
3) |
xxxxxxxxxxx |
x) |
Xxxxxxxx xxxxxxxxxxxx xxxxx xxxxxxxxxx x xxxxx xxxxxxx, xxxxxxx, xxxxxx, xxxxx, xxxx. x xxxx xxxxxx xxxxx 2,5 xx. |
|
x) |
Xxxxxxxx atropin-sulfátu xxxx xxx xxxxxxx 1 % x množství xxxxxxxxxxxx x xxxxx xxxxxxx, xxxxxxx, xxxxxx, xxxxx, xxxx. v xxxx xxxxxx xxxxx. |
||
|
4) |
xxxxxxxxxxxxxxxx |
Xxxxxxxx xxxxxxxxxxxxxxxxx |
|
|
x) |
xxxxx xxxxxxxxxx 135 xx x xxxxx xxxxxxx, tobolce, ampuli, xxxxx, xxxx. v xxxx xxxxxx formě. |
||
|
b) |
v xxxxxxx nesmí xxx xxxxxxxxxxx xxxxx než 2,5 %. |
||
|
Přípravek xxxxx xxxxxxxxx xxxxxx xxxxxxxxxxxx xxxxx. |
|||
|
5) |
xxxxxx |
Xxxxxxxx xxxxxxx nesmí xxxxxxxxxx 0,1 % xxxxxxx. |
|
|
6) |
xxxxx xxxx xxxxxx |
x) |
Xxxxxxxx xxxxxxx xxxxx xxxxxxxxxx 0,2 %. |
|
b) |
Dále xxxxx xxxxxxxxx xxxxx xxxx xxxx xxxxxxx xxxxx (xxxxxxx však xxxxxxxx). |
||
|
Xxxxxx xxxxx v xxxxxxxxx xxxxxxxx nesmí být xxxxxx získána xxxx x takovém xxxxxxxx, xxx xxxxxxxx veřejné xxxxxx |
|||
|
7) |
xxxxxxxxxxxxx prášek x xxxxx |
x) |
Xxxxxxxx xxxx x xxxxxx xxxxx být xxxxx xxx 10 %. |
|
x) |
Xxxxxxxx xxxxxxxxxxxxxxx xxxxxx xxxxx být vyšší xxx 10 %. |
||
|
c} |
Množství xxxxx xxxx více xxxxxxx látek (nikoliv xxxx ornamných) xxxxx xxx xxxxx než 80%. |
||
|
8) |
xxxxxxxxx |
x) |
Xxxxxxxxx xxxxxxxxx xxxxx xxxxxxxxxx 100 xx x jedné xxxxxxx, xxxxxxx, xxxxxx, xxxxx, xxxx. x xxxx Xxxxxx xxxxx. |
|
x) |
Xxxxxxxxx xxxxxxxxxxxxxx x xxxxxxxxx musí xxx xxxxxxx stejné xxxx vyšší xxx xxxxxxxxx. |
||
Xxxxxx xxxxxxxxxxxx vyrobených xxxxxxxxx, xxxxxxx xxxxxx xxxxxx xx vyšší xxx D4 nebo XX2.
Xxxxxx předpis x. 463/2013 Xx. nabyl xxxxxxxxx xxxx 1.1.2014.
Xx xxxxx xxxxxx xxxxxxxx xxxxxxxx xxxx podchyceny xxxxx a xxxxxxxx xxxxxxxxxxx xxxxxxx xxxxxxxxx x.:
243/2015 Xx., kterým xx xxxx xxxxxxxx xxxxx x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx
x xxxxxxxxx xx 1.10.2015
46/2017 Xx., xxxxxx se mění xxxxxxxx xxxxx x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx, xx znění xxxxxxxx xxxxx x. 243/2015 Xx.
x účinností xx 1.3.2017 x výjimkou xxxxxxxxx ustanovení, která xxxxxxxx xxxxxxxxx 1.5.2017
30/2018 Xx., xxxxxx xx xxxx xxxxxxxx xxxxx x. 463/2013 Sb., x xxxxxxxxx xxxxxxxxxx xxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx
x xxxxxxxxx xx 8.3.2018
242/2018 Xx., xxxxxx xx xxxx xxxxxxxx xxxxx x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx, xx xxxxx pozdějších xxxxxxxx
x xxxxxxxxx xx 25.10.2018
184/2021 Xx., xxxxxx xx xxxx nařízení xxxxx x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx, ve xxxxx xxxxxxxxxx xxxxxxxx
x xxxxxxxxx od 3.6.2021
159/2022 Xx., xxxxxx se xxxx xxxxxxxx xxxxx x. 463/2013 Xx., x xxxxxxxxx návykových xxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx
x xxxxxxxxx xx 1.7.2022
228/2023 Xx., xxxxxx xx xxxx xxxxxxxx xxxxx č. 463/2013 Xx., o xxxxxxxxx xxxxxxxxxx xxxxx, xx xxxxx pozdějších xxxxxxxx
x xxxxxxxxx xx 1.8.2023
52/2024 Sb., xxxxxx xx xxxx nařízení xxxxx č. 463/2013 Xx., x seznamech xxxxxxxxxx xxxxx, ve xxxxx xxxxxxxxxx xxxxxxxx
x xxxxxxxxx xx 6.3.2024 x 1.1.2025
176/2023 Xx., xxxxxx xx mění xxxxxxxx xxxxx č. 463/2013 Sb., o xxxxxxxxx xxxxxxxxxx xxxxx, xx xxxxx pozdějších xxxxxxxx
x xxxxxxxxx od 1.7.2024 a 1.1.2025
419/2024 Xx., xxxxxx xx xxxx xxxxxxxx vlády x. 463/2013 Xx., x seznamech návykových xxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx
x xxxxxxxxx xx 1.1.2025 x 1.4.2025
534/2025 Xx.,&xxxx;xxxxxx xx xxxx nařízení xxxxx x. 463/2013 Sb., x seznamech xxxxxxxxxx xxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx, x xxxxxxxx xxxxx x. 11/2025 Xx., x xxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxx
x xxxxxxxxx xx 16.12.2025 x výjimkou xxxxxxx č. 5, xxxxx xxxxxx xxxxxxxxx 1.1.2026
Xxxxx jednotlivých xxxxxxxx xxxxx xxxxxx xxxxxxxx xxxxxxxx x odkazech xxxx xxxxxxxxxxxxx, xxxxx xx xxxx netýká xxxxxxxxx xxxxx xxxxx xxxxxxxxx právního předpisu.
1) Jednotná úmluva x omamných xxxxxxx, xxxxxxxxx xxx č. 47/1965 Sb., xx xxxxx Xxxxxxxxx x xxxxxxx Jednotné xxxxxx x xxxxxxxx xxxxxxx, xxxxxxxxxxx xxx č. 458/1991 Sb.
2) Xxxxxx x xxxxxxxxxxxxxx xxxxxxx, xxxxxxxxx xxx č. 62/1989 Sb.